Drug treatment of neonatal persistent pulmonary hypertension
10.3760/cma.j.issn.1673-4912.2021.10.015
- VernacularTitle:新生儿持续性肺动脉高压药物治疗进展
- Author:
Yirui WANG
1
;
Yuting YANG
;
Jingye ZUO
;
Dongmei YUE
Author Information
1. 中国医科大学附属盛京医院新生儿科，沈阳 110004
- Keywords:
Neonatal persistent pulmonary hypertension;
Drug treatment;
Inhaled nitric oxide;
Sildenafil
- From:
Chinese Pediatric Emergency Medicine
2021;28(10):914-917
- CountryChina
- Language:Chinese
-
Abstract:
Neonatal persistent pulmonary hypertension refers to the continuous increase of pulmonary artery pressure, right heart pressure, right-to-left shunt at foramen ovale and ductus arteriosus level, severe hypoxemia and even respiratory failure after birth.At present, the drug treatments of neonatal persistent pulmonary hypertension include inhaling nitric oxide, sildenafil, milrinone, endothelin receptor antagonists bosentan, prostaglandins and their analogs.This review briefly summarized the progress on the treatment of neonatal persistent pulmonary hypertension.
